Monosialotetrahexosylganglioside
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Monosialotetrahexosylganglioside, covering 2018-02-05 to 2018-02-05. Get the full timeline:
Most recent: Clinical Trial Update: Monosialotetrahexosylganglioside for Treatment of Oxaliplatin Induced Neurotoxicity in Gastrointestinal Cancer [Phase 3]